by plexusventures_h3tnl0 | May 5, 2023 | Uncategorized
Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”). The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...
by plexusventures_h3tnl0 | Feb 17, 2023 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of an out-licensing project conducted on behalf of its client, Elthera AG of Switzerland. Plexus Ventures served as the exclusive business development advisor to Elthera in...
by plexusventures_h3tnl0 | Dec 2, 2022 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...
by plexusventures_h3tnl0 | Oct 18, 2022 | No About
Philadelphia and Prague – Mindpax, the innovative digital therapeutics company focused on improving the lives of people with Severe Mental Illnesses (SMIs), has engaged Plexus Ventures as its contract business development organization to identify partners for further...
Recent Comments